INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 412m ago
HOUSE PTR11m ago
SEC 13F11m ago
ROBINHOOD CHAIN11m ago
SEC FORM 4/Grant or awardVerified data

Artis Dean Richard reported ANNX

EVP & CHIEF SCIENTIFIC OFFICER · Annexon, Inc. · Common Stock

Side
A
Value
—
Shares
62.5K
Price
—
Executed
Feb 19, 2026
Disclosed
Feb 23, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Feb 19 executedFeb 23, 2026 disclosed

ANNX · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
17/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+13 / 25

    No reported dollar value · 50.6% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+4 / 15

    1 prior trade recorded in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · ANNX

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    36
    LD
    Love DouglasDirector, PRESIDENT AND CEO
    ANNXAnnexon, Inc.
    Open-market purchase
    		BUY$100K
    26.1K sh
    		Sep 24, 2026Sep 25, 2026
    traded Sep 24, 2026
    		+1dSEC FORM 4

    Evidence

    9
    CM
    Cockroft Bettina M.Director
    ANNXAnnexon, Inc.
    Grant or award
    		A—
    65.0K sh
    		Jun 11, 2026Jun 15, 2026
    traded Jun 11, 2026
    		+4dSEC FORM 4

    Evidence

    19
    CH
    Carson William H.Director
    ANNXAnnexon, Inc.
    Open-market purchase · 10b5-1 plan
    		BUY$50K
    8,000 sh
    		Apr 10, 2026Apr 14, 2026
    traded Apr 10, 2026
    		+4dSEC FORM 4

    Evidence

    5
    AR
    Artis Dean RichardEVP & CHIEF SCIENTIFIC OFFICER
    ANNXAnnexon, Inc.
    Grant or award
    		A—
    250.0K sh
    		Feb 19, 2026Feb 23, 2026
    traded Feb 19, 2026
    		+4dSEC FORM 4

    Evidence

    21
    AR
    Artis Dean RichardEVP & CHIEF SCIENTIFIC OFFICER
    ANNXAnnexon, Inc.
    Open-market sale
    		SELL$27K
    5,290 sh
    		Feb 18, 2026Feb 20, 2026
    traded Feb 18, 2026
    		+2dSEC FORM 4

    Evidence

    29
    CH
    Carson William H.Director
    ANNXAnnexon, Inc.
    Open-market purchase · 10b5-1 plan
    		BUY$21K
    4,115 sh
    		Dec 30, 2025Jan 2, 2026
    traded Dec 30, 2025
    		+3dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001958523-26-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Feb 19, 2026
    Published
    Feb 23, 2026
    Ingested by INSIDER
    Nov 5, 04:15 UTC
    Last re-read
    Nov 5, 04:15 UTC

    Extracted facts

    Filer
    Artis Dean Richard
    Role
    EVP & CHIEF SCIENTIFIC OFFICER
    Transaction
    Grant or awardAs filed: “A”
    Asset
    Annexon, Inc.
    Ticker
    ANNX
    Shares
    62.5K
    Price per share
    $0
    Execution date (reported)
    Feb 19, 2026
    Owned after transaction
    186.0K shares
    Days from execution to publication
    4

    What this establishes

    Artis Dean Richard filed this Form 4 reporting a grant or award of ANNX on Feb 19, 2026. It became public on Feb 23, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    EVP & CHIEF SCIENTIFIC OFFICER
    Artis Dean Richardcik:0001958523
    Issuer
    Annexon, Inc.cik:0001528115

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.